Health

  • April 16, 2026

    Trump Taps Ret. Rear Admiral Schwartz As New CDC Chief

    President Donald Trump on Thursday nominated Dr. Erica Schwartz, a retired rear admiral who served in the U.S. Coast Guard and as deputy surgeon general in the first Trump administration, to be the Centers for Disease Control and Prevention's next director.

  • April 16, 2026

    Tenn. Judge Keeps Filipino Nurses' Trafficking Suit Alive

    A Tennessee federal judge denied a bid by a long-term care provider and a foreign nursing recruiter to dismiss a proposed class action brought by Filipino nurses who alleged they were forced to sign abusive contracts that amount to "indentured servitude."

  • April 16, 2026

    HHS Defends ACA Overhaul Against Cities' Challenge

    The Health and Human Services Department is defending sweeping changes to the Affordable Care Act marketplace against attacks from three cities, asking a Maryland federal judge to grant summary judgment and allow the agency to shorten open enrollment, institute tighter income checks and charge a reenrollment verification premium.

  • April 16, 2026

    Fed. Circ. Says Judge Wrongly Axed Teva's $177M Eli Lilly Win

    The Federal Circuit ruled Thursday that a Massachusetts federal judge was wrong to overturn a $177 million jury verdict that Teva won against Eli Lilly & Co. on headache drug patents, finding that contrary to the judge's finding, the patents are not invalid.

  • April 16, 2026

    Feds Can't Stay Trans Healthcare Orders During Appeal

    The Trump administration won't be able to enforce two executive orders that ban federal funding for gender-affirming care for patients under the age of 19 while the federal government appeals a nationwide injunction blocking the orders, the Fourth Circuit ruled Thursday. 

  • April 16, 2026

    Del. Rejects Fiduciary Claim Over Competing Opioid Clinic

    The Delaware Chancery Court on Thursday largely rejected a healthcare company's claims that a former executive unlawfully competed against it by launching a nearby opioid treatment clinic, finding only a narrow breach of fiduciary duty and awarding just over $1,600 in damages.

  • April 16, 2026

    DOL Benefits Chief Pressed On Labor Secretary's Conduct

    The head of the U.S. Department of Labor's employee benefits arm faced tough questions from House Democrats at an oversight hearing Thursday, fielding questions about the labor secretary's on-the-job conduct as well as the DOL's take on mental health parity enforcement. 

  • April 16, 2026

    Texas Patients Say Defective Sutures Caused Disfigurement

    Four patients who received cosmetic facial procedures told a Texas federal court that sutures used during their procedures caused painful facial bacterial abscesses and permanent scarring, claiming the sutures never received FDA approval.

  • April 16, 2026

    Armed Services Board Says DHA Agreement Wasn't A Contract

    The Armed Services Board of Contract Appeals dismissed an appeal from a Defense Health Agency supply vendor whose agreement was terminated years before its end date, finding it did not amount to a contract.

  • April 16, 2026

    Katten Partner Rejoins Epstein Becker In DC For 3rd Time

    Epstein Becker Green LLP has rehired, for the third time, a healthcare transactional attorney who focuses his practice on guiding hospital systems, private equity-backed entities and professional practices on transactional matters and regulatory compliance.

  • April 15, 2026

    Larry King's Estate Says Supplement Co. Still Using His Name

    Larry King's estate sued operators of a prostate health supplement company in California state court Wednesday, alleging they continued using his name and likeness to advertise their product even after striking a legal settlement agreeing to stop.

  • April 15, 2026

    Consumer Cases Drive Class Action Spike, Report Says

    Federal class action filings spiked in 2025 after nearly a decade of relative stability, fueled by a surge in consumer protection lawsuits tied to data breaches, digital commerce and online accessibility claims, according to a new report from Lex Machina.

  • April 15, 2026

    'A Bunch Of Games': MDL Judge Irked By Meta, AGs Sparring

    A California federal judge appeared skeptical Wednesday of Meta Platforms Inc.'s request for a summary judgment win over claims by state attorneys general in multidistrict social media addiction litigation, saying repeatedly that many disputes should be resolved at trial and panning some arguments by both sides as "a bunch of games."

  • April 15, 2026

    Hims & Hers Providers Can't Duck Suit Over Student's Suicide

    Medical providers for telehealth company Hims & Hers can't escape a wrongful death lawsuit from the family of a Washington State University freshman who died by suicide in 2023, according to a Washington state judge's order denying summary judgment motions from five individual defendants.

  • April 15, 2026

    Amneal Trims But Can't Nix AGs' Drug Price-Fixing Suit

    There is enough evidence from which a jury could conclude that Amneal Pharmaceuticals participated in a conspiracy to fix the price of an epilepsy medication, but not enough to show it participated in the overarching antitrust conspiracy alleged by dozens of state attorneys general, a Connecticut federal judge ruled Wednesday.

  • April 15, 2026

    Drugmaker Aquestive's Brass Sued Over FDA Setback

    Executives and directors of pharmaceutical company Aquestive Therapeutics Inc. were hit with a shareholder's derivative suit Wednesday accusing them of ignoring deficiencies in a research study for Aquestive's allergic reaction treatment, which eventually prompted the U.S. Food and Drug Administration to reject the company's new drug application.

  • April 15, 2026

    'Law, Not Liturgy'?: 9th Circ. Split Over Faith Bias COVID Suit

    Eight judges dissented Wednesday from the denial of an en banc Ninth Circuit rehearing of a panel's decision not to revive a Christian hospital worker's religious bias lawsuit alleging she was fired for refusing COVID-19 nasal testing, with one dissenting judge saying "courts are unwelcome guests" when deciding the veracity of an individual's belief.

  • April 15, 2026

    Judge Won't Move 'Maya' Case For Retrial

    A Florida judge on Wednesday denied a hospital's request to move a retrial of Netflix documentary subject Maya Kowalski's claims against the hospital from Sarasota to St. Petersburg, citing the difficulty and expense of moving the 8-year-old case to a new circuit and judge.

  • April 15, 2026

    Aluminum Co. Settles Trans Worker's Suit Over Health Plan

    A subsidiary of Kaiser Aluminum has agreed to resolve a lawsuit claiming it discriminated against transgender employees by excluding coverage for medical treatments related to gender-affirming care from its health plan, according to a filing in Washington federal court.

  • April 15, 2026

    What To Know About DOL's Benefits Enforcement Update

    The U.S. Department of Labor's employee benefits arm recently issued updated enforcement guidance that highlighted the agency's goal of shifting to focus more on breaches of the fiduciary duty of loyalty under federal benefits law. Here are three things experts said stood out about the DOL's update.

  • April 15, 2026

    Women's Health Co. Accused Of Unauthorized Data Sharing

    A private women's healthcare system is facing a proposed class action in Pennsylvania federal court that alleges it allowed third parties to use sensitive patient information without consent or notice.

  • April 15, 2026

    Fertility Biz Progyny Hit With TM Suit In Pennsylvania

    Fertility benefit management company Progyny Inc.'s expansion into pregnancy and postpartum care while using the "Progyny" trademark will create confusion in the marketplace by overlapping with similar but differently spelled marks, a new lawsuit from ProgenyHealth LLC claims.

  • April 15, 2026

    Fed. Circ. Won't Make It Harder To Undo CICA Stay Overrides

    The Federal Circuit declined to impose a heightened standard of review when judges are considering a federal agency's decision to override an automatic pause on contract performance during a bid protest at the U.S. Government Accountability Office.

  • April 15, 2026

    Shell, Enviro Group Ordered To 'Actually Speak For 4 Hours'

    An apparently frustrated Connecticut federal judge on Wednesday ordered Shell and an environmental advocacy group to try to resolve remaining disputes in Clean Water Act litigation before they appear before him again, ruling that counsel "must actually speak for four hours," and "time spent composing e-mails, even lengthy ones" doesn't count.

  • April 15, 2026

    Firings Over Vax Refusals Arbitrable, Police Union Tells Court

    The union representing Massachusetts state police troopers told an intermediate appellate court Wednesday that disagreement over the meaning of "just cause" triggers a right to arbitrate disciplinary actions, including the firings of 13 officers over their refusal to receive COVID-19 vaccinations.

Expert Analysis

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • Series

    Law School's Missed Lessons: In Court, It's About Storytelling

    Author Photo

    Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.

  • Pros And Cons Of FDA's Push For Nonprescription Drugs

    Author Photo

    The U.S. Food and Drug Administration's recent moves to shift more prescription drugs to over-the-counter status could increase access to important medications, but also bring potential safety risks and other trade-offs for drug companies, say attorneys at Hogan Lovells.

  • Prepping For The Future Of No Surprises Act Enforcement

    Author Photo

    This year is expected to be a transition point for the No Surprises Act framework from regulatory delay to operational enforcement, so stakeholders should use this time to stress-test systems, clean up processes and prepare for enforcement, say attorneys at Akerman.

  • High Court's 'Skinny Label' Case May Tackle Wider Questions

    Author Photo

    The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.

  • Aligning Microsoft Tools With NYC Bar AI Recording Guidance

    Author Photo

    The New York City Bar Association’s recently issued formal opinion, providing ethical guidance on artificial intelligence-assisted recording, transcription and summarization, raises immediate questions about data governance and e-discovery for companies that use Microsoft 365 and Copilot, say Staci Kaliner, Martin Tully and John Collins at Redgrave.

  • Class Actions At The Circuit Courts: March Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses four recent rulings from January and identifies practice tips from cases involving allegations of violations of consumer fraud regulations, the Fair Credit Reporting Act, employment law and breach of contract statutes.

  • FDA's Biosimilarity Guidance Holds Uncertain Implications

    Author Photo

    The U.S. Food and Drug Administration's new draft guidance aimed at simplifying the biosimilarity demonstration process may not be enough to overcome the barriers that have historically constrained biosimilar competition, and could affect biosimilar access in unexpected ways, say analysts at Analysis Group.

  • Unpacking Key Themes From NY's New Healthcare Strategy

    Author Photo

    New York Gov. Kathy Hochul's 2026 State of the State agenda, read together with the state's fiscal year 2027 executive budget, reflect a clear framework to utilize Medicaid as the state's operating platform for healthcare reform, say attorneys at Sheppard.

  • 5 Different AI Systems Raise Distinct Privilege Issues

    Author Photo

    A New York federal court’s recent U.S. v. Heppner decision, holding that a defendant’s use of Claude was not privileged, only addressed one narrow artificial intelligence system, but lawyers must recognize that the spectrum of AI tools raises different confidentiality and privilege questions, says Heidi Nadel at HP.

  • Health Co.'s 'Success Story' Misstep Holds HIPAA Lessons

    Author Photo

    Cadia Healthcare Facilities' fall settlement with the U.S. Department of Health and Human Services for improperly disclosing patients' protected health information in online success stories is an instructive example of Health Insurance Portability and Accountability Act risks that can arise from digital marketing efforts, say attorneys at Woods Rogers.

  • Opinion

    AI-Assisted Arbitration Needs Safeguards To Ensure Fairness

    Author Photo

    As tribunals and arbitral institutions increasingly use artificial intelligence tools in their decision-making processes, ​​​​​​​clear disclosure standards and procedural safeguards are necessary to ensure that efficiency gains do not erode the fairness principles on which arbitration depends, says Alexander Lima at Wesco International.

  • Trans Care Enforcement Landscape Is Evolving Quickly

    Author Photo

    The recent coordinated federal effort to reshape pediatric gender-affirming care through enforcement and funding pressure has created a rapidly evolving regulatory environment marked by shifting risk assessments and potential downstream market effects for healthcare institutions and life sciences companies, say attorneys at Arnall Golden.

  • Series

    Playing Piano Makes Me A Better Lawyer

    Author Photo

    Playing piano and practicing law share many parallels relating to managing complexity: Just as hearing an entire musical passage in my head allows me to reliably deliver the message, thinking about the audience's impression helps me create a legal narrative that keeps the reader engaged, says Michael Shepherd at Fish & Richardson.

  • 11th Circ. May Bring Tectonic Shift To FCA Qui Tam Actions

    Author Photo

    The Eleventh Circuit's upcoming decision in Zafirov v. Florida Medical Associates, assessing whether the False Claims Act permits ordinary citizens to stand as officers of the federal government, could significantly limit private relators' ability to bring FCA actions, say attorneys at Saul Ewing.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.